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Abstract
Nowadays, the main limitation for clinical application of scaffolds is considered to be an insufficient vascularization of the 
implanted platforms and healing tissues. In our studies, we proposed a novel PLA-based hybrid platform with aligned and 
random fibrous internal structure and incorporated calcium phosphate (CaP) ormoglass nanoparticles (0, 10, 20 and 30 wt%) 
as an off-the-shelf method for obtaining scaffolds with pro-angiogenic properties. Complex morphological and physicochemi-
cal evaluation of PLA–CaP ormoglass composites was performed before and after in vitro degradation test in SBF solution to 
assess their biological potential. The degradation process of PLA–CaP ormoglass composites was accompanied by numerous 
CaP-based precipitations with extended topography and cauliflower-like shape which may enhance bonding of the material 
with the bone tissue and accelerate the regenerative process. Random fiber orientation was preferable for CaP compounds 
deposition upon in vitro degradation. CaP compounds precipitated firstly for randomly oriented composite nonwovens with 
20 and 30 wt% addition of ormoglass. Moreover, the preliminary bioactivity test has shown that BSA adsorbed to PLA–CaP 
ormoglass composites (both aligned and randomly oriented) with 20 and 30 wt% of ormoglass nanoparticles which was not 
observed for pure PLA scaffolds.
Keywords Composites · PLA · Calcium phosphate ormoglass · Electrospinning · Degradation
1 Introduction
Bone tissue is based on fibrous structures which are organ-
ized hierarchically. Therefore, nanofiber biomaterials are 
currently under deep investigation in the field of bone tis-
sue regeneration. It has been shown that scaffolds possess-
ing nanofibrous structure have beneficial impact on cel-
lular responsiveness as they exhibit similarity in physical 
architecture to native extracellular matrix (ECM) [1–3]. 
Scaffolds obtained via electrospinning mimic bone ECM 
structure very trustworthy. Hence, they are widely inves-
tigated in the field of bone tissue engineering. Due to their 
easy formability and degradability, thermoplastic aliphatic 
polyester is commonly used to fabricate scaffolds. However, 
their mechanical properties as well as bioactivity and cell 
signaling are often insufficient. Thus, composite materials 
are now widely investigated to be commonly adapted in bone 
regeneration applications. Among them, combination of pol-
ylactic acid (PLA) as a polymer matrix and soluble calcium 
phosphate (CaP) glass–ceramics in form of nanoparticles 
as a reinforcement seems to be very promising candidate 
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[4–6]. PLA is one of the most commonly used materials for 
biomedical applications due to its desirable properties such 
as biodegradability, good compatibility and low toxicity [7]. 
Nowadays, PLA can be obtained from renewable resources 
at relatively low costs, requires low energy consumption 
during production and can be easily thermally processed 
compared to other polymers [8]. It has been approved in 
different applications by the Food and Drug Administration 
(FDA) and has been extensively studied and used in novel 
scaffolds for tissue repair. Besides, product of PLA degrada-
tion-lactate-has been reported to show an angiogenic effect 
by supporting expression of vascular endothelial growth fac-
tor (VEGF) [9].
Due to its biological potential, PLA is often used as the 
main component of composites for biomedical applica-
tions. In order to increase its mechanical strength as well as 
bioactivity, different types of ceramic components such as 
bioactive glasses are commonly used additives. Bioactive 
glasses have been extensively investigated in recent years 
in various fields of study due to their ability to promote 
gene expression regulating osteogenesis and angiogenesis 
[10]. Gritsch et al. provided recently an overview on strat-
egies to improve tissue–material interface for polylactide-
based materials, concerning among them different types of 
bioactive glasses [11]. Mao et al. reported previously that 
incorporation of bioactive glass to PLA-based composite 
significantly improved its bioactivity. They claimed that deg-
radation rate of such composite scaffolds could be easily 
regulated by adjusting the bioactive glass content to match 
the regeneration process of new bone [12]. There are evi-
dences that PLA–bioactive glass composites can promote 
hydroxyapatite formation upon in vitro degradation [13, 
14]. Bellucci et al. claimed that bioactive glass can release 
VEGF upon in vitro degradation which suggests its angio-
genic potential [15].
Apart from bioactive glass, calcium phosphate organi-
cally modified glasses (CaP ormoglasses) can be used to 
increase the biological potential of PLA-based composites. 
It has been demonstrated that CaP ormoglasses in the sys-
tem  P2O5–CaO–Na2O–TiO2 possess interesting mechanical, 
bioactive and degradation properties [16–18]. They degrade 
totally in body fluids within time ranging from few days to 
several months, releasing in that period  Ca2+ ions. The most 
promising feature is its ability to trigger the angiogenic pro-
cess and promote the formation of vessels, as has been stud-
ied both in vitro [19] and in vivo [20]. Recently, Navarro-
Requena et al. reported as well on wound healing-promoting 
effects of such CaP ormoglasses that can stimulate wound 
healing responses of dermal fibroblasts [21].
In this paper, nanofibrous composite material made of 
PLA matrix and nanoparticles of CaP ormoglass fabri-
cated by electrospinning was investigated as an envelope 
which mimics the periosteum to maintain a filling for bone 
regeneration. The key issues here are to provide a high bio-
active nonwoven electrospun scaffold to allow the envel-
opment of a bone filler. CaP bioresorbable ormoglasses, 
which have controllable solubility and the ability to trigger 
the angiogenic process, were incorporated into polymeric 
fibers to obtain a hybrid material suitable for bone regen-
eration applications. Electrospun mats were fabricated hav-
ing two types of fiber orientation: aligned (a) and randomly 
oriented (r). Different concentrations of ormoglass filler 
(0, 10, 20 and 30 wt%) were investigated to determine its 
effect on biological properties. Complex morphological and 
physicochemical evaluation of composite scaffolds as well 
as in vitro degradation test in simulated body fluid (SBF) 
solution was made in order to obtain overall material charac-
teristic and assess their potential angiogenic properties. The 
preliminary bioactivity test was also conducted with simple 
protein adsorption test using bovine serum albumin (BSA) 
as a model protein.
2  Materials and methods
2.1  Sample preparation
Poly-l/dl lactic acid 70/30 (PLA70/30 Corbion PLDL 7038, 
inherent viscosity midpoint 3.8 dl g−1, molecular mass ≈ 
850,000 Da, Gorinchem, The Netherlands) was used as the 
composite matrix. Ormoglass nanoparticles with a compo-
sition of 59:30:8:3 P/Ca/Na/Ti molar ratio were prepared 
by controlled sol–gel hydrolysis and added as a filler to the 
composites. The ormoglass production method consisting 
of mixing different alkoxide precursors of Ca, Na, Ti and 
P in an Ar-controlled atmosphere was reported previously 
[22]. The mixes were hydrolyzed in basic aqueous media, 
dispersed and stirred in anhydrous 1,4-dioxane (Sigma-
Aldrich 99.8%) for 4 days at 70 °C. They were then washed, 
collected by centrifugation and dried at 85 °C. Electrospin-
ning slurries were prepared by ultrasonically dispersing 
ormoglass nanoparticles (0, 10, 20 and 30 wt% respect total 
weight of polymer plus particles) in a solution of PLA 70/30 
4 wt% in 2,2,2-trifluoroethanol (Panreac 99.8%). Then, they 
were electrospun at 10 kV with a 15-cm tip–collector dis-
tance using a rotary (aligned nonwovens) or flat (randomly 
oriented nonwovens) collector working at 1000 rpm. The 
obtained electrospun scaffolds with different concentrations 
of CaP ormoglass, i.e., 0, 10, 20 and 30 wt%, are further 
referred to as PLA, PLA10GS, PLA20GS and PLA30GS, 
respectively.
2.2  In vitro degradation
In vitro degradation studies were carried out using SBF pre-
pared following the standard procedure described by Kokubo 
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et al. [23]. Briefly, NaCl (8.035 g),  NaHCO3 (0.355 g), KCl 
(0.225 g),  K2HPO4∙3H2O (0.231 g), MgCl∙6H2O (0.311 g), 
1 M HCl (39 ml),  CaCl2 (0.292 g),  Na2SO4 (0.072 g) and 
Tris (6.118 g) were dissolved individually in deionized water 
in order to avoid precipitation and maintain the pH in the 
range. Final pH was 7.4 at 37 °C. Electrospun nonwovens for 
the biomineralization study were cut into rectangular pieces 
with dimensions 8 × 15 mm (thickness of each nonwoven 
was in the range of 200–250 μm) and immersed separately in 
12 ml of medium at 37 °C for 21 days. The SBF solution was 
refreshed every 3 days to ensure sufficient ions concentra-
tion. At predetermined control points (1, 7, 14 and 21 days), 
samples were removed from the SBF, rinsed gently with 
deionized water and dried.
2.3  SEM/STEM observation and EDS measurements
The morphology of electrospun nonwovens before and dur-
ing controlled degradation in SBF solution was character-
ized using scanning electron microscope (SEM) Hitachi 
SU8000 operating at 5 kV and scanning transmission elec-
tron microscope (STEM) Hitachi S5500 with an applied 
voltage of 30 kV. In order to improve surface conductance, 
samples were sputtered for 120 s with gold at voltage of 
2 kV and current of 5 mA. Fibers diameter was measured 
with ImageJ software, and at least 50 measures were done 
for each sample. Elemental composition of the surface was 
characterized by energy-dispersive X-ray (EDS) analysis 
coupled with SEM Hitachi SU8000. To obtain chemical 
distribution maps, voltage of 15 kV was applied.
2.4  FTIR measurements
The changes in chemistry after incubation in SBF were 
examined using Fourier transform infrared spectroscopy 
(FTIR, Thermo Electron Nicolet 8700, Thermo Scientific). 
FTIR spectra were collected in the range from 4000 to 
400 cm−1 with resolution at 4 cm−1.
2.5  XPS measurements
Chemical state and composition of each element on the 
surface of nonwoven materials before and after degrada-
tion in SBF were determined using a Microlab 350 spec-
trometer (Thermo Electron Corporation) with X-ray pho-
toelectron spectroscopy (XPS) function. XPS spectrums 
were excited using Al Kα (hv = 1486.6  eV) radiation 
as a source. Survey and high-resolution spectrum were 
recorded using 150 and 40 eV pass energy. A linear or 
Shirley background subtraction was made to obtain XPS 
signal intensity. The peaks were fitted using an asymmet-
ric Gaussian/Lorentzian mixed function. The measured 
binding energies were corrected referring to energy of C1s 
at 285.0 eV. The spectra were developed using Avantage 
software (version 5.41).
2.6  Protein adsorption
For initial evaluation of the biocompatibility of nonwovens 
fibers, protein adsorption test was performed using BSA 
(Sigma-Aldrich, 99.8%) as a “model” protein. BSA has been 
chosen due to its chemical inertness to many biochemical 
reactions as well as low cost. BSA was dissolved (1 g ml−1) 
in phosphate-buffered saline (pH 7.4), and 100 µl of the 
solution was added to each sample. All tested materials were 
incubated at 37 °C for 20 min and then subjected to surface 
chemical composition analysis using FTIR spectroscopy.
3  Results
3.1  Pre‑degradation
3.1.1  SEM/STEM observation
PLA–CaP ormoglass composites obtained via electro-
spinning method possess a nonwoven fibrous structure as 
shown in Fig. 1. For aligned nonwovens, pure PLA scaf-
fold exhibits the minimum average value of fiber diameter, 
i.e., 287 ± 69 nm, whereas PLA–CaP ormoglass compos-
ites consist of fibers with the average diameter of approxi-
mately 400 nm. For randomly oriented nonwovens, the aver-
age fiber diameter values are much higher, i.e., 902 ± 232, 
845 ± 68, 955 ± 245 and 584 ± 103 nm for rPLA, rPLA10GS, 
rPLA20GS and rPLA30GS, respectively. The differences in 
obtained values of fiber diameter can be attributed to specific 
fabrication method.
As shown in Fig. 1, pure PLA fibers possess homoge-
neous structure without visible beads or other significant 
defects with uniform thickness throughout their length. 
For aligned nonwovens, high linear orientation of fibers 
is observed. In case of PLA–CaP ormoglass composites, 
fibers possess homogeneous structure and are uniform in 
their thickness as well. Round particles of ormoglass can be 
detected in the scaffold structure in small amount. STEM 
images reveal the CaP ormoglass particles incorporated into 
fibers and protruded from them. They possess miscellane-
ous shapes and sizes ranging from approximately 150 to 
700 nm. Smaller particles seem to have more round shape 
and be enclosed inside the polymer fiber, whereas the bigger 
particles stacked out from the fibers and be rather polyhe-
dron shape. STEM images for pure PLA fibers demonstrate 
smooth structure without any internal elements.
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3.1.2  FTIR measurements
Figure 2 presents results obtained for FTIR examination 
of chemical composition of PLA–CaP ormoglass com-
posites and pure PLA nonwovens. Both aligned and ran-
domly oriented nonwovens were examined. All spectra 
show several main regions corresponding to the polymer 
matrix: C=O stretching at 1750–1745 cm−1, C–H bending 
at 1500–1400 cm−1 and C–O stretching at 1100–1000 cm−1 
[24]. For PLA–CaP ormoglass composites, additional sig-
nals can be distinguished due to the presence of phosphate 
complexes: P–O–P asymmetric stretching at 910 cm−1 [25, 
Fig. 1  Morphology of aligned and randomly oriented PLA–CaP ormoglass composites at initial state
Fig. 2  FTIR results for a aligned and b randomly oriented PLA–CaP ormoglass composites at initial state
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26] and region between 480 and 600 cm−1 relating to the 
bending vibrations O–P–O and O=P–O in phosphate groups 
[25, 27]. The intensity of those peaks increases for higher 
content of ormoglass filler which suggests they are related to 
the vibration of  PO4 phosphate groups in CaP ormoglass as 
shown in our previous work [28]. No significant differences 
can be observed between aligned and randomly oriented 
nonwovens.
3.2  Post‑degradation
3.2.1  SEM observation
Figures 3 and 4 present results of SEM observation of 
PLA–CaP ormoglass composites after incubation in SBF 
solution after 1, 7, 14 and 21 days of the test for aligned and 
random orientation, respectively. Significant changes in the 
morphology of reference pure PLA sample and PLA–CaP 
ormoglass composites upon incubation can be observed. 
Numerous perforation and traversal cracks can be found on 
the fibers as well as thin film of melted polymer which is a 
result of hydrolytic degradation of the composite matrix. 
The cracking and dissolving of the fibers lead to partial loss 
of initial microstructure and linearity of aligned nonwovens. 
The degradation process is accompanied by precipitation 
from SBF of characteristic particles with developed surface 
area resembling cauliflower-like shape (marked by white 
arrows). These particles were recognized by EDS analysis 
as CaP-based precipitates as shown in Fig. 4.
Comparing aligned and randomly oriented PLA–CaP 
ormoglass composites, random fiber orientation seems to be 
preferable for CaP compounds deposition upon in vitro deg-
radation. CaP compounds precipitate firstly for rPLA20GS 
and rPLA30GS samples after 7 days of incubation. Longer 
incubation in SBF (14 and 21 days) results in further miner-
alization of all randomly oriented PLA–CaP ormoglass com-
posites. Mineralization process is not so clearly observed 
for aligned nonwovens. Small amounts of CaP precipitate 
for aPLA20GS and aPLA30GS composites after 21 days of 
incubation.
It should be mentioned that no CaP compounds pre-
cipitate in case of pure PLA nonwovens (both aligned and 
randomly oriented). The most pronounced mineralization 
process was observed for rPLA20GS composite, and there-
fore, the degradation process will be further discussed on the 
example of that composite.
3.2.2  FTIR and XPS measurements
Figure 5 presents FTIR results of chemical analysis of 
rPLA20GS after incubation in SBF. There are a few 
Fig. 3  Morphology of aligned PLA–CaP ormoglass composites after incubation in SBF solution for 1, 7 and 21 days
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differences in the spectra compared to the initial state. 
All peaks related to the presence of CaP ormoglass, i.e., 
at 910 cm−1 as well as those in the region from 480 to 
600 cm−1, have disappeared after 1 day of incubation. After 
14 days of incubation, additional peaks were detected at 
559 and 601 cm−1 which also represent  v4 O–P–O bending 
vibrations of  PO4 groups in phosphates [29–32]. This result 
coincides with SEM observation, i.e., the most pronounced 
precipitation of CaP particles was observed after 14 days of 
incubation.
Table 1 presents the results of XPS investigation for 
rPLA20GS scaffolds before and after incubation in SBF. 
Analysis of the results shows that content of calcium and 
phosphorus increases after incubation in SBF. It is also clear 
that Ca/P ratio rises gradually with incubation time. This 
result coincides with SEM observation of cauliflower-like 
shape CaP-based particles precipitated at the surface of com-
posite scaffolds (Fig. 4).
The significant reduction of C and O content at the 
expense of Ca and P can be clearly observed after 21 days 
of incubation. As shown in Fig. 6, it may result from the 
degradation of PLA matrix of scaffolds. Figure 6 shows 
the C1s XPS spectra of pure PLA scaffold before (Fig. 6a) 
and after (Fig. 6b) the degradation test in SBF solution 
Fig. 4  Morphology of randomly oriented PLA–CaP ormoglass composites after incubation in SBF solution for 1, 7, 14 and 21 days and EDS 
analysis for rPLA20GS after 7 days of incubation
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for 21 days. A new characteristic peak of C1s at 287.5 eV 
after the degradation test can be distinguished. The new 
C1s peak is related to the degradation products of PLA 
such as C1s (C–O and O–C–O) bonding types. It results 
from the hydrolysis and degradation of the ester groups 
of the PLA main chain under incubation in SBF solution 
(aqueous solution).
3.3  Protein adsorption
The results of the preliminary test of biocompatibility (pro-
tein adsorption test using BSA) are presented in Fig. 7. 
There is a slight change in the spectra for aligned (Fig. 7a) 
and randomly oriented (Fig. 7b) PLA–CaP ormoglass com-
posites with 20 and 30 wt% addition of ormoglass nanopar-
ticles as compared to the initial state. Small peaks at ~ 1655 
and ~ 1540 cm−1 have appeared for these composites. The 
first peak corresponds mostly to the stretching vibrations 
of the C=O groups and less to the C–N groups present in 
amides I. The second lower peak at ~ 1540 cm−1 correlates 
mainly with bending of N–H group in amide II [33].
4  Discussion
In this paper, evaluation of structural and chemical changes 
of electrospun PLA–CaP ormoglass composites after in vitro 
simulated degradation in physiological conditions (SBF 
solution) was studied. The addition of ormoglass nanopar-
ticles modified the degradation of PLA–CaP ormoglass 
Fig. 5  FTIR results for rPLA20GS after incubation in SBF for 1, 7, 
14 and 21 days
Table 1  Chemical composition 
(in at.%) of rPLA20GS after 
incubation in SBF
Incubation time C O Ca P Ti Na Mg Cl Ca/P
Initial state 70.0 27.5 0.5 1.5 0.2 0.3 – – 0.33
1 day 68.6 27.4 1.1 1.7 0.3 0.1 0.1 0.7 0.65
7 days 68.0 28.8 0.9 1.2 0.3 0.1 0.1 0.6 0.75
14 days 68.2 28.2 0.8 1.4 0.4 0.1 0.1 0.8 0.57
21 days 62.7 30.3 3.0 3.3 0.3 0.1 0.1 0.2 0.91
Fig. 6  XPS results for rPLA a before and b after incubation in SBF for 21 days
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composites and caused differences in the morphology and 
chemical properties of material surface. Referring to the 
changes in the morphology after various periods of SBF 
incubation, the presence of CaP precipitations partly cover-
ing the nonwovens was observed only for PLA–CaP ormo-
glass composites (Figs. 3, 4). No CaP compounds formed 
in case of pure PLA nonwovens (both aligned and randomly 
oriented) which indicates that CaP ormoglass nanoparticles 
initiate and highly accelerate the precipitation process of 
CaP compounds. Besides, it should be noted that random 
fiber orientation strongly favored CaP formation. For ran-
domly oriented scaffolds (rPLA20GS and rPLA30GS), CaP 
compounds precipitated after 7 days of incubation, whereas 
for aligned ones (aPLA20GS and aPLA30GS) only small 
CaP precipitates were observed after 21 days of incubation. 
The extended topography of detected CaP particles may 
improve the bioactivity and biological response of the elec-
trospun PLA–CaP ormoglass composites. Developed sur-
face area of those precipitations can promote bonding the 
material with the bone tissue accelerating the regeneration 
process of bone fracture.
The another important aspect of bone regeneration 
process in case of the investigated PLA–CaP ormoglass 
composites is the chemical composition of CaP precipi-
tates formed during degradation test. FTIR analysis for 
rPLA20GS composite showed the presence of additional 
peaks representing O–P–O bending vibrations after 14 days 
of incubation (Fig. 5) which are characteristics for  PO4 
groups in phosphates and hydroxyapatites [29–32]. However, 
further analysis of chemical composition of the scaffolds 
surface (Table 1) exhibited significantly lower Ca/P ratio 
than for hydroxyapatite (1.67). Ca/P ratio from the range of 
0.5–1.0 suggests the occurrence of other calcium phosphates 
such as calcium metaphosphate Ca(PO3)2 (Ca/P = 0.5), hep-
tacalcium phosphate  Ca7(P5O16)2 (0.7), calcium phosphate 
 Ca2P2O7 (1.0) or dicalcium phosphate  CaHPO4 [34].
Due to the relatively high reactivity of the added parti-
cles, traversal cracks in the fibers can occur together with 
separation in the interconnection area of polymer matrix and 
glass–ceramic particles [4]. Those places with interrupted 
continuity promote release of degradation products to the 
incubation solution which, on the one hand, enhance the 
degradation process, but, on the other hand, influence the 
pH value. The most suitable range of pH values for proteins 
and other biological molecules in most of the body fluids is 
from 7.35 to 7.45 [35]. Significant deviations in pH values 
upon degradation of the scaffold can cause inflammatory 
reactions and pose a threat to tissue recovery. Therefore, 
it is of great importance to maintain the pH of surround-
ing tissue medium in preferable range [36, 37]. As shown 
in Fig. 6, the investigated PLA–CaP ormoglass composites 
undergo a hydrolytic degradation during incubation in SBF. 
The degradation process of PLA induces production of 
carboxylic acid which may significantly decrease the pH. 
Table 2 presents the pH values after 21 days of incubation of 
PLA–CaP ormoglass composites in SBF solution. It is clear 
that the incorporation of the CaP ormoglass nanoparticles 
into the PLA matrix impedes the decrease in medium pH 
and allows to sustain it in the right range. The addition of 20 
and 30 wt% of CaP ormoglass helps to maintain the pH in 
the range of 7.35–7.45 after 3 weeks of incubation in SBF.
Finally, the protein adsorption test was done to assay 
whether electrospun PLA–CaP ormoglass composites 
can support protein anchorage to the surface and there-
fore improve the efficiency of binding the scaffold with 
the tissue. It is a crucial matter to investigate the protein 
Fig. 7  FTIR results for a aligned and b randomly oriented PLA–CaP ormoglass composites after protein adsorption test using bovine serum 
albumin (BSA)
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adsorption on the biomaterial surface as it is the first 
stage of interaction between material and body fluids and 
it influences the proper cell adhesion [17, 38, 39]. FTIR 
results (Fig. 7) indicate that despite low concentration of 
protein solution, BSA adsorbed to PLA–CaP ormoglass 
composites (both aligned and randomly oriented) with 20 
and 30 wt% of ormoglass nanoparticles which was not 
observed for pure PLA scaffolds. It was manifested by the 
presence of two additional peaks at ~ 1655 and ~ 1540 cm−1 
for these composites which corresponds to C=O as well 
as C–N groups in amides I and N–H bending in amide II, 
respectively [33].
BSA is well known for its good calcium-binding prop-
erties [40], and the ormoglass nanoparticles consist of a 
significant amount of calcium (30 wt%). Therefore, better 
molecule adsorption on the materials with higher ormoglass 
concentration results from higher Ca concentration and more 
numerous binding sites available for proteins. Besides, it 
has been reported that both BSA and PLA fibers exhibit 
electronegative potential. The addition of ormoglass may 
increase the affinity of the protein to the composite fibers 
by changing its surface charges [17].
The promising results of degradation test in SBF and pro-
tein adsorption on the surface of the investigated PLA–CaP 
ormoglass composites suggest these hybrid fibrous scaf-
folds have a great potential for clinical use in bone tissue 
engineering. Our strategy toward development of the smart 
biomaterials platform for guided bone regeneration is based 
on a simple and cost-efficient fabrication method which is 
realistic to a clinical perspective, and materials able to pro-
mote angiogenesis and enhance vascularization in vivo.
5  Conclusions
Hybrid PLA–CaP ormoglass composites with different 
ormoglass nanoparticles contents (0, 10, 20 and 30 wt%) 
and fibers orientation (aligned and random) were success-
fully fabricated via electrospinning. Complex morphologi-
cal and physicochemical analysis of PLA–CaP ormoglass 
composites before and after in vitro degradation test in SBF 
solution confirmed their biological potential which can be 
summarized as follows:
1. The presence of ormoglass nanoparticles in PLA/CaP 
ormoglass composites may promote bone regeneration 
by enhancing degradation process by Ca release and 
formation of CaP-based precipitations. The degradation 
process of PLA/CaP ormoglass nonwovens was accom-
panied by precipitation of numerous CaP compounds 
with extended topography and cauliflower-like shape, 
whereas no CaP compounds formed in case of pure PLA 
nonwovens (both aligned and randomly oriented).
2. Random fiber orientation seems to be preferable for CaP 
compounds deposition upon in vitro degradation. CaP 
compounds precipitated firstly for randomly oriented 
composite nonwovens with 20 and 30 wt% addition of 
ormoglass after 7 days of incubation in SBF, whereas 
for their aligned counterparts only small amounts of CaP 
precipitates were observed after 21 days of incubation.
3. The investigated PLA–CaP ormoglass composites 
underwent a hydrolytic degradation during incubation 
in SBF, which results in carboxylic acid production and 
decrease in pH value. However, the incorporation of 
the CaP ormoglass nanoparticles into the PLA matrix 
impedes the decrease in medium pH and allows to sus-
tain it in the right range of 7.35–7.45 after 3 weeks of 
incubation in SBF.
4. Moreover, the protein adsorption test exhibited that the 
presence of ormoglass nanoparticles increases the bio-
activity of PLA–CaP ormoglass composites. The bovine 
serum albumin (used as a model protein) adsorbed to 
composite nonwovens (both aligned and randomly ori-
ented) with 20 and 30 wt% of ormoglass which was not 
observed for pure PLA scaffolds.
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Table 2  The pH values of 
incubation medium after 
21 days for PLA–CaP 
ormoglass composites
Material pH value
aPLA 7.33 ± 0.04
aPLA10GS 7.34 ± 0.04
aPLA20GS 7.38 ± 0.03
aPLA30GS 7.38 ± 0.04
rPLA 7.33 ± 0.04
rPLA10GS 7.35 ± 0.03
rPLA20GS 7.37 ± 0.04
rPLA30GS 7.41 ± 0.03
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included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
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